Total n=194 Total n=194 Favipiravir n(%)=101(52.1) HQ n(%)=93(47.9)
p-value*
Baseline HR, bpm 89±12 89±12 89±12 90±11 0.64
Baseline PR, ms 151±15 151±15 151±14 150±15 0.63
Baseline QTc, ms 402±20 402±20 400±21 404±20 0.14
Final HR, bpm 78±14 78±14 73±16 82±12 <0.001
Final PR, ms 161±20 161±20 162±19 159±20 0.21
Final QTc, ms 417±27 417±27 413±23 421±31 0.04
ΔHR, bpm 8 (-8­—70) 8 (-8­—70) 12 (-6—70) 5 (-8—41) <0.001
ΔPR, ms 8 (-11—77) 8 (-11—77) 9 (-11—77) 7 (-8—50) 0.08
ΔQTc, ms 12 (-9—103) 12 (-9—103) 11 (-9—57) 12 (-7—103) 0.59
Arrhythmias, n (%) 32 (16.4) 32 (16.4) 20 (19.8) 13 (13.9) 0.42
Sinus bradycardia 16 (8.2) 16 (8.2) 13 (12.9) 3 (3.2) 0.01
First-degree AV block 3 (1.5) 3 (1.5) 1 (1) 2 (2.2) 0.51
Third-degree AV block Third-degree AV block 5 (2.6) 4 (4) 1 (1.1) 0.37
Nonsustained VT Nonsustained VT 2 (1) 0 (0) 2 (2) 0.49
QTc prolongation QTc prolongation 12 (6.2) 3 (3) 9 (9.7) 0.04